TOP – THORACIC ONCOLOGY PADOVA Impact of practice-changing trials on the multidisciplinary tumor board: hot topics

Lung cancer remains one of the most challenging malignancies worldwide, with continuous advancements in diagnostic and therapeutic strategies reshaping clinical practice. Multidisciplinary tumor boards play a pivotal role in integrating emerging data from practice-changing trials into real-world decision-making, ensuring optimal patient care.
The 5th edition of the Thoracic Oncology Padova (TOP) congress aims to provide a comprehensive update on the latest advancements in thoracic oncology, focusing on how pivotal trials influence daily clinical practice. This year’s event will bring together leading experts to discuss crucial topics, including resectable non-oncogene addicted NSCLC, borderline resectable disease, the impact of oncogene addiction on resectability and treatment sequencing, early relapse management, and the role of local treatment in stage IV disease.
Through interactive case discussions, expert lectures, and panel debates, the congress will facilitate an in-depth analysis of complex clinical scenarios, offering a multidisciplinary perspective that encompasses surgery, medical oncology, radiation therapy, and pathology.
By bridging the gap between research and clinical application, TOP 5 Padova will provide attendees with valuable insights to refine their approach to thoracic malignancies, ultimately improving patient outcomes.